Histamine-2 receptor antagonists as immunomodulators: new therapeutic views?
Considerable evidence has emerged to suggest that histamine participates in the regulation of the inflammatory response, immune reaction, coagulation cascade, and cardiovascular function. Furthermore, histamine may play a major role in the growth of normal and malignant tissue as a regulator of proliferation and angiogenesis. Specific histamine receptors have been identified on the surface of bone marrow cells, immune competent cells, endothelial cells, fibroblasts, and also on malignant cells. This has prompted research in regulation by specific histamine receptor agonists and antagonists. Results from such studies are currently accumulating and suggest that the histamine-2 receptor antagonists have potential beneficial effects in the treatment of certain malignant, autoimmune and skin diseases, either alone or in combination with other drugs. The beneficial effect of histamine-2 receptor antagonists as adjuvant single drugs to reduce trauma-, blood transfusion- and sepsis-induced immunosuppression has led to research in combined treatment regimens in major surgery, particularly, of patients operated on for malignant diseases.
Nielsen
H J
HJ
Department of Surgical Gastroenterology, Hvidovre University Hospital, Denmark.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D001327:Autoimmune Diseases / Q000628:therapy; D002986:Clinical Trials as Topic; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D016867:Immunocompromised Host; D007167:Immunotherapy; D007938:Leukemia / Q000628:therapy; D009369:Neoplasms / Q000628:therapy; D011565:Psoriasis / Q000628:therapy
D000276:Adjuvants, Immunologic; D006635:Histamine H2 Antagonists